nach oben

Tipp

Stent-supported percutaneous transluminal angioplasty in patients suffering from symptomatic benign or malignant central venous occlusive disease

verfasst von: K. Linni, MD, A. Ugurluoglu, M. Aspalter, W. Hitzl, T. Hölzenbein

Erschienen in: European Surgery | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Summary

Background

The aim of this study was to investigate the outcome of patients suffering from benign or malignant superior vena cava (SVC), brachiocephalic (BCV), and subclavian (SV) vein lesions treated with nitinol stents.

Methods

Retrospective analysis of consecutive patients in a university-based tertiary care center.

Results

Twenty-two patients suffering from central venous occlusive disease (CVD) (9 malignant, mean age 58 years; 13 benign, mean age 66 years) were treated 2/2003–1/2012. In total, 89 % of malignant central venous occlusive disease (mCVD) patients underwent successful primary stenting (one reintervention 6 months after primary stenting). Two stent occlusions (22 %) were seen at last follow-up. All mCVD patients died within a median follow-up of 2 months (range: 0.8–54 months). In all, 92 % of benign central venous occlusive disease (bCVD) patients underwent primary stenting of SV (n = 8), BCV (n = 5), and SVC (n = 1). Six repeat interventions were performed in 42 % of patients. There was one stent occlusion (8 %) at last follow-up. Of all, 69 % of bCVD patients died within a median follow-up of 12.7 months (range: 1.3–82 months); 22 % of mCVD and 8 % of bCVD patients underwent bypass surgery as bail out procedure due to primary (n = 2) or secondary (n = 1) endovascular failure. All CVD patients experienced immediate post-interventional relief of symptoms.

Conclusion

Technical success of CVD stenting is high and leads to immediate relief of symptoms in patients with short life expectancy.

Vorheriger Artikel Patch, interposition graft or stent for treatment of restenosis after carotid endarterectomy: a retrospective study

Nächster Artikel High correlation of lung ultrasound and chest X-ray after tube drainage in patients with primary spontaneous pneumothorax: can we omit X-rays for tube management?

Parish JM, Marschke RF, Dines DE, Lee RE. Etiologic considerations in superior vena cava syndrome. Mayo Clin Proc. 1981;56:407–13. PubMed

Ostler PJ, Clarke DP, Watkinson AF, Gaze MN. Superior vena cava obstruction: a modern management strategy. Clin Oncol. 1997;9:83–9. CrossRef

Charnsangavej C, Carrasco CH, Wallace S, Gianturco C, et al. Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology. 1986;161:295–8. PubMedCrossRef

Urruticoechea A, Mesia R, Dominguez J, et al. Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer. Lung Cancer. 2004;43:209–14. PubMedCrossRef

Agarwal AK, Patel BM, Farhan NJ. Central venous stenosis in hemodialysis patients is a common complication of ipsilateral central vein catheterization. J Am Soc Nephrol. 2004;15:368–9A. CrossRef

Topf G, Jenkins P, Guttmann FD, Rieselbach RE, Saltzstein EC. Unilateral breast enlargement: a complication of an arterio-venous fistula and coincidental subclavian vein occlusion. JAMA. 1977;237:571–2. PubMedCrossRef

Dethlefsen S, Shepro D, D’Amore PA. Comparison of the effects of mechanical stimulation on venous and arterial smooth muscle cells in vitro. J Vasc Res. 1996;33:405–13. PubMedCrossRef

NKF-K/DOQUI clinical practice guidelines for vascular access. update 2000. Am J Kidney Dis. 2001;37:S137–81.

Aruny JE, Lewis CA, Cardella JF, Cole PE, Davis A, Drooz AT. Quality improvement guidelines for percutaneous management of the thrombosed or dysfunctional dialysis access. Standards of Practise Committee of the Society of Cardiovascular & Interventional Radiology. J Vasc Interv Radiol. 2003;14:S247–53. PubMedCrossRef

10.

Haage P, Vorwerk D, Piroth W, Schuemann K, Guenther RW. Treatment of hemodialysis-related central stenosis or occlusion: results of primary Wallstent placement and follow-up in 50 patients. Radiology. 1999;121:175–80. CrossRef

11.

Mickley V, Gorich J, Rilinger N, Storck M, Abendroth D. Stenting of central venous stenoses in hemodialysis patients: long-term results. Kidney Int. 1997;51:277–80. PubMedCrossRef

12.

Quinn SF, Schuman ES, Demlow TA, et al. Percutaneous transluminal angioplasty versus endovascular stent placement in the treatment of venous stenoses in patients undergoing hemodialysis: intermediate results. J Vasc Interv Radiol. 1995;6:851–5. PubMedCrossRef

13.

Shoenfeld R, Hermans H, Novick A, et al. Stenting of proximal venous obstructions to maintain hemodialysis access. J Vasc Surg. 1994;9:532–9. CrossRef

14.

Vogel PM, Parise CP. SMART stent for salvage of hemodialysis access grafts. J Vasc Interv Radiol. 2004;15(10):1051–60. PubMedCrossRef

15.

Fagedet D, Thony F, Timsit JF, et al. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol. 2013;36(1):140–9. PubMedCrossRef

16.

Canales JF, Cardenas JC, Dougherty K, Krajcer Z. Single center experience with percutaneous endovascular repair of superior vena cava syndrome. Catheter Cardiovasc Interv. 2011;77(5):733–9. PubMedCrossRef

17.

Stanford W, Jolles H, Ell S, Chiu LC. Superior vena cava obstruction: venographic classification. AJR Am J Roentgenol. 1987;148:259–62. PubMedCrossRef

18.

Dondelinger R. Chronic upper extremity/superior vena cava venous occlusive disease. In: Mauro M, Murphy K, Thomson K, Venbrux A, Zollikofer C, editors. Image guided interventions. Philadelphia: Saunders Elsevier; 2008. pp. 1055–65.

19.

Günther RW, Vorwerk D, Bohndorf K, et al. Venous stenoses in dialysis shunts: treatment with self-expanding metallic stents. Radiology. 1989;170(2):401–5. PubMedCrossRef

20.

Gloviczki P, Kalra M. Surgical treatment of superior vena cava obstruction. In: Cronenwett JL, editor. Rutherford’s vascular surgery. 7th ed. Philadelphia: W.B. Saunders; 2010. pp. 963–75. CrossRef

21.

Kishi K, Sonomura T, Mitsuzane K, et al. Self-expandable stent therapy for superior vena cava syndrome: clinical observations. Radiology. 1993;189:531–5. PubMedCrossRef

22.

Hill T, Lewicki P. STATISTICS methods and applications. Tulsa: StatSoft; 2007.

23.

Wolfram Research, Inc. Mathematica, Version 7.0, Champaign: Wolfram Research, Inc.; 2008.

24.

Goeckenjan G, Sitter H, Thomas M, et al. Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society-abridged version. Pneumologie. 2011;65(8):e51–75. PubMedCrossRef

25.

Nagata T, Makutani S, Uchida H, et al. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava. Cardiovasc Intervent Radiol. 2007;30(5):959–67. PubMedCrossRef

26.

Lanciego C, Pangua C, Chacon JI, et al. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. AJR Am J Roentgenol. 2009;193(2):549–58. PubMedCrossRef

27.

Ganeshan A, Hon LQ, Warakaulle DR, Morgan R, Uberoi R. Superior vena caval stenting for SVC obstruction: current status. Eur J Radiol. 2009;71:343–9. PubMedCrossRef

28.

de Gregorio AMA, Gamboa P, Gimeno MJ, et al. Percutaneous treatment of superior vena cava syndrome using metallic stents. Eur Radiol. 2003;13:853–62.

29.

Matsushita J, Morita S, Suzuki K, et al. Pull-through technique with pincer tactics for stent placement in severe superior vena cava syndrome. Ann Vasc Surg. 2012;26(3):421.e11–5. CrossRef

30.

Ingram TL, Reid SH, Tisnado J, Cho SR, Posner MP. Percutaneous transluminal angioplasty of brachiocephalic vein stenoses in patients with dialysis shunts. Radiology. 1988;166:45–7. PubMedCrossRef

31.

Kovalik EC, Newman GE, Suhocki P, Knelson M, Schwab SJ. Correction of central venous stenoses: use of angioplasty and vascular Wallstents. Kidney Int. 1994;45(4):1177–81. PubMedCrossRef

32.

Kundu S. Central venous obstruction management. Semin Intervent Radiol. 2009;26(2):115–21. PubMedCentralPubMedCrossRef

33.

Dammers R, de Haan MW, Planken NR, van der Sande FM, Tordoir JH. Central vein obstruction in hemodialysis patients: results of radiological and surgical intervention. Eur J Vasc Endovasc Surg. 2003;26(3):317–21. PubMedCrossRef

34.

Lumsden AB, MacDonald MJ, Isiklar H, et al. Central venous stenosis in the hemodialysis patient: incidence and efficacy of endovascular treatment. Cardiovasc Surg. 1997;5(5):504–9. PubMedCrossRef

35.

Oderich GS, Treiman GS, Schneider P, Bhirangi K. Stent placement for treatment of central and peripheral venous obstruction: a long-term multi-institutional experience. J Vasc Surg. 2000;32:760–9. PubMedCrossRef

36.

Bakken AM, Protack CD, Saad WE, Lee DE, Waldman DL, Davies MG. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients. J Vasc Surg. 2007;45:776–83. PubMedCrossRef

37.

Glanz S, Gordon D, Butt KMH, Hong J, Adamson R, Sclafani SJ. Dialysis access fistulas: treatment of stenoses by transluminal angioplasty. Radiology. 1984;152(3):637–42. PubMedCrossRef

38.

Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int. 1992;42:1390–7. PubMedCrossRef

39.

Surowiec SM, Fegley AJ, Tanski WJ, et al. Endovascular management of central venous stenoses in the hemodialysis patient: results of percutaneous therapy. Vasc Endovasc Surg. 2004;38(4):349–54. CrossRef

40.

Himmelfarb J, Ikizler TA. Hemodialysis. N Eng J Med. 2010;363:1833–45 CrossRef

41.

Gradman WS, Bressman P, Sernaque JD. Subclavian vein repair in patients with an ipsilateral arteriovenous fistula. Ann Vasc Surg. 1994;8:549–56. PubMedCrossRef

Titel: Stent-supported percutaneous transluminal angioplasty in patients suffering from symptomatic benign or malignant central venous occlusive disease
verfasst von: K. Linni, MD
A. Ugurluoglu
M. Aspalter
W. Hitzl
T. Hölzenbein
Publikationsdatum: 01.08.2015
Verlag: Springer Vienna
Erschienen in: European Surgery / Ausgabe 4/2015
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI: https://doi.org/10.1007/s10353-015-0325-9

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Stent-supported percutaneous transluminal angioplasty in patients suffering from symptomatic benign or malignant central venous occlusive disease

Summary

Background

Methods

Results

Conclusion

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Summary

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

Bilateral superficial cervical plexus block combined with bilateral greater occipital nerve block reduces the impact of different sources of pain after thyroid surgery with less consumption of morphine-PCA: a randomized trial

Littoral cell angioma of the spleen: case report and literature review

High correlation of lung ultrasound and chest X-ray after tube drainage in patients with primary spontaneous pneumothorax: can we omit X-rays for tube management?

Diagnosis and treatment of benign inflammatory esophageal diseases

How to report multiple outcome metrics in virtual reality simulation

Morbidity reduction using the vessel sealing device LigaSure™ in breast cancer surgery